LYEL - Lyell Immunopharma strengthens clinical and commercial capabilities with executive appointments June, 10 2025 01:52 AM Lyell Immunopharma Inc. 2025-06-10 01:52:53 ET More on Lyell Immunopharma Lyell Immunopharma gets FDA RMAT status for lymphoma treatment Seeking Alpha’s Quant Rating on Lyell Immunopharma Historical earnings data for Lyell Immunopharma Financial information for Lyell Immunopharma For further details see: Lyell Immunopharma strengthens clinical and commercial capabilities with executive appointments